Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amir Shabaka

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Kidney International|November 9, 2020
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathyGema Fernández-Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt, et al.
Nefrologia|September 4, 2023
Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registryMaría O López-Oliva, Isabel Pérez-Flores, María Molina, et al.
Kidney International Reports|August 7, 2023
Effect of Immunosuppressive Treatments on Kidney Outcomes After Gross Hematuria-Related Acute Kidney Injury in Older Patients With IgA NephropathyAngel M Sevillano, Fernando Caravaca-Fontán, Lucia Cordero Garcia-Galan, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|May 9, 2022
[Management of immunosuppressive therapy in kidney transplant recipients with COVID19. A multicentre national study derived form the S.E.N. COVID registry.]María O López-Oliva, Isabel Pérez-Flores, María Molina, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 18, 2019
IgA Nephropathy in Elderly PatientsAngel M Sevillano, Monserrat Diaz, Fernando Caravaca-Fontán, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 28, 2020
Validation of a Histologic Scoring Index for C3 GlomerulopathyFernando Caravaca-Fontán, Hernando Trujillo, Marina Alonso, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 13, 2020
Use of tocilizumab in kidney transplant recipients with COVID-19María J Pérez-Sáez, Miquel Blasco, Dolores Redondo-Pachón, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2021
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathyFernando Caravaca-Fontán, Montserrat Díaz-Encarnación, Virginia Cabello, et al.
Clinical Kidney Journal|August 25, 2022
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathyFernando Caravaca-Fontán, Marta Rivero, Teresa Cavero, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2020
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the DiseaseFernando Caravaca-Fontán, Montserrat M Díaz-Encarnación, Laura Lucientes, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Kidney International|November 9, 2020
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathyGema Fernández-Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt, et al.
Nefrologia|September 4, 2023
Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registryMaría O López-Oliva, Isabel Pérez-Flores, María Molina, et al.
Kidney International Reports|August 7, 2023
Effect of Immunosuppressive Treatments on Kidney Outcomes After Gross Hematuria-Related Acute Kidney Injury in Older Patients With IgA NephropathyAngel M Sevillano, Fernando Caravaca-Fontán, Lucia Cordero Garcia-Galan, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|May 9, 2022
[Management of immunosuppressive therapy in kidney transplant recipients with COVID19. A multicentre national study derived form the S.E.N. COVID registry.]María O López-Oliva, Isabel Pérez-Flores, María Molina, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 18, 2019
IgA Nephropathy in Elderly PatientsAngel M Sevillano, Monserrat Diaz, Fernando Caravaca-Fontán, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 28, 2020
Validation of a Histologic Scoring Index for C3 GlomerulopathyFernando Caravaca-Fontán, Hernando Trujillo, Marina Alonso, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 13, 2020
Use of tocilizumab in kidney transplant recipients with COVID-19María J Pérez-Sáez, Miquel Blasco, Dolores Redondo-Pachón, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 29, 2021
Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathyFernando Caravaca-Fontán, Montserrat Díaz-Encarnación, Virginia Cabello, et al.
Clinical Kidney Journal|August 25, 2022
Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathyFernando Caravaca-Fontán, Marta Rivero, Teresa Cavero, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2020
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the DiseaseFernando Caravaca-Fontán, Montserrat M Díaz-Encarnación, Laura Lucientes, et al.
Pageof 6